Send me a link:

*Text messaging rates may apply.

 Dow Down 0.72% Nasdaq Down 0.50%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
303.09 1.35(0.44%) Jul 25, 4:00PM EDT
Prev Close:304.44
Open:303.46
Bid:102.59 x 200
Ask:323.53 x 600
1y Target Est:345.83
Beta:0.86
Next Earnings Date: 5-Aug-14REGN Earnings announcement
Day's Range:300.22 - 305.01
52wk Range:227.64 - 352.49
Volume:369,087
Avg Vol (3m):830,730
Market Cap:29.92B
P/E (ttm):86.90
EPS (ttm):3.49
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNDown 0.44%29.92B
AMGN92.99B
NVS214.50B
RHHBY250.55B

Key Statistics

Forward P/E (1 yr):25.07
P/S (ttm):13.12
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :9.91
Quarterly EPS Est (Jun-14) :2.28
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.49

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback